Prognosis of 148 New Cases of Female Genital Fistula in a Multicentric Study in Niger

HTML  XML Download Download as PDF (Size: 201KB)  PP. 1197-1201  
DOI: 10.4236/ojog.2019.98116    643 Downloads   1,453 Views  

ABSTRACT

Introduction: We report anatomopathological and treatment results of new cases of obstetrical female genital fistula in main to determine the prognosis. Methodology: Multicentre prospective study over 15 months (January 1st, 2016 to March 31st, 2017) in 5 national centres of female genital fistula treatment. Patients were in all age group. Anatomopathological types were urogenital classified simple, middle and mixte (association of urogenital and recto genital). The methods of treatment were surgery and trans uretral vesical probe. We observed treated patients during 3 months. Results: 148 new cases collected. The study revealed 47.15% of urogenital fistulas were vesico-vaginal and urethro-vaginal (25.71%). 3 cases of rectovaginal fistula including 2 cases in the lower third of the rectum and one in the upper third, 141 patients were treated. The results gave 35 cases treated by trans ureterovesical probe cured and dry, those by surgery were continent and dry (71.62%) but 23 (15.54%) treated but not dry, 12 (4.10%) FGF were not closed tTab5) 7 cases not treated, one referred to urology service, one patient died before treatment and 5 perdu of view. Conclusion: Obstetric fistula remains a serious public health problem in Niger. FGF happened in all age old because of non skilled pre- and per-natal care particularly in rural area. Treatment could be improved but political prevention must be the rule.

Share and Cite:

Idi, N. , Brah, N. , Idrissa, A. , Djangnikpo, L. and Assoumana, Z. (2019) Prognosis of 148 New Cases of Female Genital Fistula in a Multicentric Study in Niger. Open Journal of Obstetrics and Gynecology, 9, 1197-1201. doi: 10.4236/ojog.2019.98116.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.